Last updated on November 2017

An Open-label, Randomized, Actual Use Study of Dupilumab Auto-injector Device in Patients With Atopic Dermatitis


Brief description of study

An Open-label, Randomized, Actual Use Study of Dupilumab Auto-injector Device in Patients With Atopic Dermatitis

Detailed Study Description

To collect data on actual-use to assess technical performance and user injections of dupilumab auto-injection device by patients with atopic dermatitis (AD).

Clinical Study Identifier: TX14043

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Renee Smith

University of South Florida- Asthma, Allergy, and Immunology Clinical Research Unit
Tampa, FL USA
  Connect »